← Leaderboards
Bin Xu
Virginia Polytechnic Inst And St Univ
$1,112,920
Attributed
$3,988,616
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $842.2K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,988,616 · 2
By mechanism
R01$3,834,262 · 1
R03$154,354 · 1
Top collaborators
- Shu G Chen5 shared
- Allison L Kraus5 shared
- Zerui Wang5 shared
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposSamplingS DiseaseNeurobehavioralAnimal ModelDepositionBrainDementiaAnimalsCreutzfeldt-Jakob SyndromeClinical TrialsCerebrospinal FluidCorticobasal DegenerationBrain InjuriesBiochemicalBrain TissueBiopsy SpecimenAlpha SynucleinBlindedBiological MarkersAutopsyBrain ImagingAreaAmyloid Beta-Protein
Grant awards (7)
Skin biomarkers for diagnosing and characterizing AD and ADRD$727,876
R01 · FY2025 · AG
Skin biomarkers for diagnosing and characterizing AD and ADRD$751,076
R01 · FY2024 · AG
Skin biomarkers for diagnosing and characterizing AD and ADRD$757,758
R01 · FY2023 · AG
Skin biomarkers for diagnosing and characterizing AD and ADRD$755,388
R01 · FY2022 · AG
Skin biomarkers for diagnosing and characterizing AD and ADRD$842,164
R01 · FY2021 · AG
Pilot Study on Novel Compounds for the Prevention of Aging-related diabetic Hyperamylinemia$74,000
R03 · FY2020 · AG · contact PI
Pilot Study on Novel Compounds for the Prevention of Aging-related diabetic Hyperamylinemia$80,354
R03 · FY2019 · AG · contact PI